CAR-TCR Europe 2021

February 16 - 18, 2021 - GB

Hanson Wade

With CAR-TCR therapies on the cusp of achieving global approval, there are still many bottlenecks that are preventing this from becoming the 'sell-out' therapy that the field had hoped for. The CAR-TCR Summit Europe 2021 will unravel the technical challenges across R and D, translation, scale and delivery to provide your team with the platform to learn, collaborate and gain actionable insights to advance your therapy for clinical and commercial success. This year's focused agenda will delve into the technical bottlenecks encountered in every stage of the CAR-TCR drug development cycle, providing more comprehensive analysis across 3 tracks including: Research and Development; Translation; and, Manufacturing and Commercialisation.

More Information